April 26, 2005 (Press Release) --
Aethlon Medical CEO Provides Corporate Update
Aethlon Medical, Inc. (OTCBB: AEMD) www.aethlonmedical.com announced that its Chairman & CEO, James A. Joyce, provided a corporate update during an interview with The Wall Street Reporter today. The interview can be accessed at www.wallstreetreporter.com through Thursday, April 28th. Mr. Joyce discussed Aethlon's upcoming HIV & HCV clinical trials, and detailed the Company's strategy to commercialize its Hemopurifier(TM) treatment technology as a first line of defense against drug and vaccine resistant bioweapons.
Disclaimer: www.investorideas.com/about/disclaimer
Full News: www.investorideas.com/Companies/ViewDocument.asp?ID=2933
Aethlon Medical, Inc. (OTCBB: AEMD) www.aethlonmedical.com announced that its Chairman & CEO, James A. Joyce, provided a corporate update during an interview with The Wall Street Reporter today. The interview can be accessed at www.wallstreetreporter.com through Thursday, April 28th. Mr. Joyce discussed Aethlon's upcoming HIV & HCV clinical trials, and detailed the Company's strategy to commercialize its Hemopurifier(TM) treatment technology as a first line of defense against drug and vaccine resistant bioweapons.
Disclaimer: www.investorideas.com/about/disclaimer
Full News: www.investorideas.com/Companies/ViewDocument.asp?ID=2933

Aethlon Medical, Inc. announced that its Chairman & CEO, James A. Joyce, provided a corporate update during an interview with The Wall Street Reporter today.
Email
Print
SPAM
LEAVE A COMMENT





